These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17564323)

  • 1. The influence of ketoconazole on the activity of asparagine protease produced by Candida strains.
    Kurnatowski P; Grabek A
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():265-76. PubMed ID: 17564323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro investigations of Candida strains for itraconazole].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(1):23-7. PubMed ID: 2554367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The sensitivity to ketoconazole of Candida strains isolated from the digestive tract ontocenoses in children].
    Horwatt-Bozyczko E; Kurnatowski M; Wasowska-Królikowska K; Kurnatowska A
    Wiad Parazytol; 2001; 47(4):929-33. PubMed ID: 16886449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the susceptibility of Candida strains to ketoconazole and itraconazole in in vitro experiments].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(5-6):399-404. PubMed ID: 2561924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes.
    Shams-Ghahfarokhi M; Shokoohamiri MR; Amirrajab N; Moghadasi B; Ghajari A; Zeini F; Sadeghi G; Razzaghi-Abyaneh M
    Fitoterapia; 2006 Jun; 77(4):321-3. PubMed ID: 16690223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
    Shin S; Pyun MS
    Phytother Res; 2004 Oct; 18(10):827-30. PubMed ID: 15551395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of electromagnetic waves on sensitivity of fungi of the genus Candida to miconazole.
    Kurnatowski P; Klimiuk C; Głowacka A
    Wiad Parazytol; 2003; 49(1):61-71. PubMed ID: 16889019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds.
    Konter J; Möllmann U; Lehmann J
    Bioorg Med Chem; 2008 Sep; 16(17):8294-300. PubMed ID: 18710813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine application of the evaluation of yeasts susceptibility to the main antimycotic drugs.
    Lombardi G; Cavanna C; Gramegna G; Scevola D; Michelone G
    Microbiologica; 1987 Apr; 10(2):189-96. PubMed ID: 3587067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of the azole drugs in vitro against strains of Candida albicans with different codes isolated from the digestive tract in children].
    Kurnatowski M; Kurnatowska A; Wasowska-Królikowska K
    Wiad Parazytol; 2004; 50(3):387-92. PubMed ID: 16865942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
    J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
    Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
    Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients.
    Traboulsi RS; Mukherjee PK; Ghannoum MA
    Int J Antimicrob Agents; 2008 Mar; 31(3):272-6. PubMed ID: 18242063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invitro drug sensitivity of Trichophyton species against griseofulvin and ketoconazole.
    Dodia S; Bajpai R; Singh BG
    Hindustan Antibiot Bull; 2002; 44(1-4):47-8. PubMed ID: 15061594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility to itraconazole and miconazole of fungi strains isolated from the vaginal ontocenosis].
    Kurnatowska A; Kołtuńska M; Horwatt-Bozyczko E
    Wiad Parazytol; 2001; 47 Suppl 1():131-5. PubMed ID: 16897964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of antimycotic antibiotics produced in Poland: Nystatin and Polyfungin against Candida strains cultured from various clinical material].
    Orlowska M; Paciorkiewicz W
    Pol Tyg Lek; 1973 Jan; 28(1):12-4. PubMed ID: 4686232
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of R126638 and ketoconazole against Malassezia species.
    Faergemann J; Ausma J; Borgers M
    Acta Derm Venereol; 2006; 86(4):312-5. PubMed ID: 16874415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.